STOCK TITAN

Alcon Canada launches new TOTAL toric lenses for astigmatic patients

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary

Alcon (SIX/NYSE: ALC) has announced the launch of TOTAL30 for Astigmatism and DAILIES TOTAL1 for Astigmatism in Canada, expanding its range of innovative contact lenses for astigmatic patients. As the toric lens segment is rapidly growing, with only 10% of the 47% of patients needing correction currently using toric lenses, this launch addresses a significant market gap. The lenses utilize Alcon's proprietary Water Gradient technology, providing enhanced comfort and moisture retention. With added features like PRECISION BALANCE 8|4 lens design and CELLIGENT™ Technology, these products aim to improve wearers' experiences significantly.

Positive
  • Launch of TOTAL30 and DAILIES TOTAL1 for Astigmatism enhances product portfolio.
  • Toric lenses are the fastest growing segment in the contact lens market, indicating potential for sales growth.
  • The new lenses offer improved comfort and stable vision, addressing common user complaints.
Negative
  • None.
  • Introducing TOTAL30 for Astigmatism and DAILIES TOTAL1 for Astigmatism: the first Water Gradient contact lenses for patients with astigmatism
  • New innovations for patients with astigmatism aim to provide brilliant vision and exceptional comfort to the fastest-growing contact lens market segment*

TORONTO--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the Canadian launch of TOTAL30® for Astigmatism and DAILIES TOTAL1® for Astigmatism. This launch extends Alcon’s portfolio of reusable and daily disposable lenses, with high-performing options designed for astigmatic patients.

TOTAL30® for Astigmatism and DAILIES TOTAL1® for Astigmatism. (Photo: Business Wire)

TOTAL30® for Astigmatism and DAILIES TOTAL1® for Astigmatism. (Photo: Business Wire)

Estimates show that toric lenses – for astigmatic correction – is the fastest growing segment of the contact lens market,* presenting an opportunity for eye care professionals to provide outstanding vision correction and patient experience. Though 47 percent of patients require astigmatic correction, studies show only 10 percent of them wear toric lenses.1**

“We’re proud to bring TOTAL30 for Astigmatism contact lenses to Canada, alongside DAILIES TOTAL1 for Astigmatism lenses which have been tremendously successful in other markets,” said Chris Gruhn, General Manager of Alcon Canada. “These eagerly anticipated innovations will provide astigmatic patients with stable vision and outstanding overall comfort, delivering on our purpose to help people see brilliantly.”

Studies show toric lens wearers experience more discomfort compared to sphere lens wearers (42% vs. 35%) and end-of-day dryness (35% vs. 26%).2 Featuring Alcon’s proprietary Water Gradient material, the new TOTAL toric lenses address these concerns, with a lens that is nearly 100% water at its surface so all that touches the eye is a gentle cushion of moisture.3,4

“Many contact lens wearers expect some discomfort or dryness to be the norm, and this is especially true for toric wearers,”2 said Dr. Christine Misener, O.D. at the Ancaster Eye Clinic. “My patients have seen success in TOTAL contact lenses, and now, I have a comfortable option for astigmatic patients too with the same innovative Water Gradient lens technology.”

These innovations also feature other proprietary technologies from Alcon designed to help provide patients with the ultimate wearing experience:

  • The PRECISION BALANCE 8|4® lens design provides the on-eye stability astigmatic contact lens wearers need for exceptionally clear and stable vision.5
  • The reusable, Water Gradient design of TOTAL30 for Astigmatism features biomimetic CELLIGENT™ Technology, which helps resist bacteria and lipid deposits for a clean lens all month long.6-9
  • DAILIES TOTAL1 for Astigmatism features SmarTears® Technology, which releases an ingredient found naturally in tears that helps to stabilize the lipid layer of the tear film.4

Eye care professionals can visit www.myalcon.ca to find out how TOTAL toric contact lenses can benefit their practice and patients with astigmatism. Please see product instructions for full wear, care and safety information.

See product instructions for complete wear, care and safety information.

About Alcon

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 24,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.ca. You can also connect with us on Instagram and Facebook.

About Astigmatism

Astigmatism is a common vision problem with 47 percent of patients requiring astigmatic correction.1** Those with an astigmatism have an irregularly shaped cornea, as opposed to spherical, which can cause fuzzy, blurred vision and make images appear stretched. Other symptoms of astigmatism can include headaches, eye fatigue and discomfort, squinting and difficulty with night vision.

* Alcon Internal Estimates
** >0.75D in at least one eye

References

  1. Young G, Sulley A, Hunt C. Prevalence of astigmatism in relation to soft contact lens fitting. Eye Contact Lens. 2011;37:20-25.
  2. Multi-sponsor Surveys Inc. The 2014 Gallup target market report on the market for toric contact lenses.
  3. Angelini TE, Nixon RM, Dunn AC, et al. Viscoelasticicty and mesh-size at the surface of hydrogels, characterized with microrheology. Invest Ophthalmol Vis Sci. 2013; 54:E-Abstract 500.
  4. Pitt WG, Jack DR, Zhao Y, Nelson JL, Pruitt JD. Loading and release of a phospholipid from contact lenses. Optom Vis Sci. 2011; 88(4); 502-506.
  5. In a clinical study wherein patients (n=66) used AOSEPT® solution for nightly cleaning, disinfecting, and storing; Alcon data on file, 2021.
  6. Ishihara K, Fukazawa K, Sharma V, Liang S, et al. Antifouling silicone hydrogel contact lenses with a bioinspired 2-methacryloyloxyethyl phosphorylcholine polymer surface. ACS Omega. 2021;6:7058-7067.
  7. In vitro evaluation of bacterial adherence in commercial lenses: Alcon data on file, 2020.
  8. In vitro evaluation of bacterial biofilm in commercial lenses: Alcon data on file, 2020.
  9. In vitro evaluation of lipid deposition for lehfilcon A and commercial lenses using 3D confocal imaging; Alcon data on file, 2021.

Connect with us on Facebook and LinkedIn.

Media Relations

Jane Lee Cheung

+ 1 289 290 2393 (Toronto)

jane.leecheung@alcon.com

Source: Alcon

FAQ

What is the significance of the launch of TOTAL30 and DAILIES TOTAL1 for Astigmatism by Alcon?

The launch expands Alcon's offerings in the rapidly growing astigmatism contact lens market, aiming to meet the needs of patients who currently have limited options.

How do TOTAL30 and DAILIES TOTAL1 for Astigmatism improve user experience?

These lenses utilize Water Gradient technology to provide enhanced moisture and comfort, addressing issues like dryness and discomfort commonly reported by toric lens wearers.

What is Alcon's stock symbol?

Alcon trades under the stock symbol ALC on the Swiss and New York Stock Exchanges.

What percentage of patients require astigmatic correction?

Approximately 47 percent of patients require astigmatic correction, but only 10 percent currently use toric lenses.

What technologies are featured in Alcon's new contact lenses?

The lenses include PRECISION BALANCE 8|4 lens design and CELLIGENT™ Technology to provide stability and resist deposits, enhancing comfort.

Alcon Inc. Ordinary Shares

NYSE:ALC

ALC Rankings

ALC Latest News

ALC Stock Data

42.36B
493.82M
0.14%
66.63%
0.64%
Medical Instruments & Supplies
Healthcare
Link
United States of America
Geneva